E-Articles - Health and Fitness

Obesity is an age-old health condition. Regard for it differ among cultures but it is mostly and especially today, considered a health problem. The condit

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ion spread throughout the world like an epidemic gravely hitting developed countries where food and sources of food is abundant. For years we’ve struggled

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

against it but more and more people become subject to it. Obese people become more common despite the low regard for it. Some treat obesity simply as una

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ttractive, some consider it a major health problem. Society as a whole prefers the slim figure. The medical society advocates prevention and treatment of

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

besity due to the string of health conditions brought by obesity. The food industry are of little help to the situation, profiting no matter what the worl

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

d chooses to eat. The people, however, we can’t seem to help ourselves as we continue to indulge in whatever food no matter how much problems they can cau

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

se. As obesity climbs the charts, we turn to science for help. Despite the numerous diets, exercise programs, drugs and surgery, we’re still struggling ag

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ainst it. But now science responds with a vaccine.

Several groups of scientists are racing to publicly release an obesity vaccine to fight the global thr

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

at. Immunopharmacotherapy is proving to be effective in fighting obesity from within.

One study by the Scripps Research Institute has developed an obesit

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

y vaccine directed against a naturally occurring hormone named Ghrelin. The hormone regulates eating behavior and assists in regulating the body’s energy.

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

It encourages the body to eat, gain weight and store fat. The obesity vaccine creates antibodies that will prevent Ghrelin from reaching the central nerv

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ous system in order to reduce weight gain. By removing the hormone away from the bloodstream, the body retains its current body fat and gains the very lit

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

le weight.

Another group from Cytos Biotechnology AG, Zurich, Switzerland, has also developed a similar Ghrelin-based obesity vaccine. It has the same ai

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

m of producing antibodies to prevent Ghelin from entering the brain.

This approach in treating obesity may be very effective compared to numerous diets a

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

nd surgery procedures. Although the benefits of preventing obesity from such a minute but highly influential element of the body are showing great rewards

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

, it does not seem to target the source of the problem. If all other approaches have been exhausted without positive results, can we rely on an obesity va

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

cine to actually solve the problem? One of the causes of obesity is over-eating and inactivity. The reason behind those vary and are quite elusive that d

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

etermining which caused which is like a mobius strip. There is an underlying problem that may grow to dangerous fields. A vaccinated person may have the t

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

endency to disregard modify his eating habits due to the vaccine that prevents him from gaining weight. This does not solve the problem of over-eating. Th

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

e world need to be responsible enough not to make a problem out of solution. When or if that happens, the world would then be ready for an obesity vaccine

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/261627/e-article-Obesity-Vaccine-A-Cure-to-the-Epidemic.html">Obesity Vaccine: A Cure to the Epidemic?</a>

BB link (for phorums):
[url=http://www.e-article.org.ua/article/261627/e-article-Obesity-Vaccine-A-Cure-to-the-Epidemic.html]Obesity Vaccine: A Cure to the Epidemic?[/url]

Traffic is the bread and butter of any website or blog. Without traffic you cannot create a revenue and you will end up being the only person visiting. There are many different ways to build traffic, but what people tend to over look is that any real and legitimate traffic building ways takes time. You normally won't do something traffic related and see 2000 people show up to your page. Some of the good ways to advertise includes:

Things you need to know about debt consolidation loans and how to go about getting the best rate to ensure you can start focusing on successful financial planning.

To work with a publisher, you’ll need to send out query letters and/or a book proposal. This is a letter or a few pages briefly describing your text, why it is unique, characteristics of your target market and how you can help market the book. Most publishers don’t accept unsolicited manuscripts, so you’ll need to convince them to read yours. If they request that you forward your entire manuscript, you have one foot in the door. Be prepared to send more than one query and don’t expect a response next week.

Tags

Links

E-Articles - Obesity Vaccine: A Cure to the Epidemic?

Related Articles: